Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Profound Medical Corp
PROF
Primary Symbol:
T.PRN
Healthcare
Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure...
, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:PRN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
(4)
•••
rocko65
X
View Profile
View Bullboard History
Post by
rocko65
on Dec 14, 2022 5:40pm
financing?
was my thought, either way nice to see things move in the right direction.
(51)
•••
snootchybootchy
X
View Profile
View Bullboard History
Post by
snootchybootchy
on Dec 14, 2022 4:36pm
What's going on?
Stock has doubled in a week and nearly tripled in 7 weeks. Feels like T.PRN is getting acquired. One could surmise this is just a bounce from the bottom but there are lots of small/micro cap medical
...more
(27)
•••
homer111
X
View Profile
View Bullboard History
Post by
homer111
on Nov 30, 2022 10:53am
Previous post
My apologies - my post was for another board, obviously....
(27)
•••
homer111
X
View Profile
View Bullboard History
Post by
homer111
on Nov 30, 2022 10:51am
BB Credit Suisse 26th Annual Tech. Conference Transcript
https://seekingalpha.com/article/4561286-blackberry-limited-bb-credit-suisse-26th-annual-technology-conference-transcript Long read but very informative: BlackBerry Limited (NYSE:BB) Credit Suisse
...more
(4)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Comment by
HomerAndCompany
on Nov 25, 2022 9:01am
RE:RE:RE:Concerns over new ways to fight cancer
The share price was more than halved within 2 months of the Sept 2 press reslease in which they put off their applicaton for a permant "CPT" billing code until 2023. Delays in acquiring a
...more
(27)
•••
homer111
X
View Profile
View Bullboard History
Comment by
homer111
on Nov 23, 2022 9:56am
RE:RE:Concerns over new ways to fight cancer
Ok - thanks, from one homer to another... I know PRN has been down huge, with most other stocks currently, so I wasn't sure whether that was to do with new technologies/competition or whether
...more
(4)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Post by
HomerAndCompany
on Nov 14, 2022 11:52am
Q3 Financial Results Webcast, Nov 3, 2022:30 sites in US now
30 sites in the US now, and they say that they're on track for 35 sites by 2023. New agreement with Halo Diagnostics "Very pleased with TACT data"
(4)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Comment by
HomerAndCompany
on Nov 08, 2022 7:53am
RE:Concerns over new ways to fight cancer
From what I've read the use of mRNA to treat cancer is something that has been in the works for more than a decade. It's one of a number of new prostate cancer and BPH treatments that are or
...more
(27)
•••
homer111
X
View Profile
View Bullboard History
Post by
homer111
on Oct 25, 2022 1:30pm
Concerns over new ways to fight cancer
Is anyone here worried how researchers are now using some of these mRNA vaccines (similar to the covid vaccines) to treat cancer and whether that may take some momentum away from PRN?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 06, 2022 4:30pm
New Press Release - Profound Medical to Participate in September Investor Conferences
TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 02, 2022 12:05pm
New Press Release - Profound Medical Provides TULSA-PRO® Reimbursement Update
TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today provided a U.S...
read article.
(2)
•••
Charlie263
X
View Profile
View Bullboard History
Comment by
Charlie263
on Aug 26, 2022 11:01pm
RE:RE:RE:if you build it they will come
Recurring revenue should double sd per CEO's comments from one of the earlier investor conference. I think approval of CPT code is the key Catalyst.
(4)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Comment by
HomerAndCompany
on Aug 12, 2022 10:25am
RE:RE:if you build it they will come
Q4 revenue double Q2? That's well into exponential growth teritory & would boost my faith too. Did you get that from the latest results webcast or.....? Thanks!
(2)
•••
Charlie263
X
View Profile
View Bullboard History
Comment by
Charlie263
on Aug 11, 2022 4:19pm
RE:if you build it they will come
As per CEO, Q4 revenue should be double of current revenue. If that happens, my faith in Proufound' strategy will be further Strenghtened.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario